In_vitro_study_of_the_interaction_of_doxorubicin,_thiotepa,_and_mitomycin-C,_agents_used_for_intravesical_chemotherapy_of_superficial_bladder_cancer._Several_cytotoxic_agents_have_been_identified_as_effective_in_the_treatment_of_superficial_transitional_cell_carcinoma_of_the_bladder,_including_doxorubicin,_thiotepa_and_mitomycin-C._An_in_vitro_study_was_conducted_to_assess_the_interactions_of_these_three_drugs_against_a_well_differentiated_human_bladder_tumor_cell_line,_RT-4,_to_identify_and_evaluate_synergistic_combinations_among_these_agents._Cytotoxicity_was_evaluated_by_a_colorimetric_assay_based_on_the_capacity_of_viable_cells_to_metabolize_a_tetrazolium_dye,_MTT,_to_produce_a_colored_formazan_product._The_analyses_of_drug_interactions_were_done_by_the_isobolographic_method_(construction_of_isoeffect_plots)._The_combination_of_doxorubicin_and_thiotepa_was_found_to_be_the_most_synergistic,_followed_by_the_combination_of_doxorubicin_and_mitomycin-C._The_combination_of_mitomycin_C_and_thiotepa_demonstrated_an_unpredictable_effect._These_findings_suggest_the_combination_of_doxorubicin_and_thiotepa_has_potential_advantage_for_chemotherapy_of_superficial_bladder_tumors.